| Celecoxib sensitizes imatinib-resistant K562 cells to imatinib by inhibiting MRP1–5, ABCA2 and ABCG2 transporters via Wnt and Ras signaling pathways G Dharmapuri, R Doneti, GH Philip, AM Kalle Leukemia research 39 (7), 696-701, 2015 | 61 | 2015 |
| Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and In Vitro Evaluation of Its Antiproliferative and Proapoptotic Effects on Cervical Cancer A Pasha, DV Kumbhakar, R Doneti, K Kumar, G Dharmapuri, ... Oxidative Medicine and Cellular Longevity 2021 (1), 6692628, 2021 | 30 | 2021 |
| Identification of Differentially Expressed Genes in Cervical Cancer Patients by Comparative Transcriptome Analysis SD Annapurna, D Pasumarthi, A Pasha, R Doneti, B Sheela, ... | 26* | 2021 |
| Role of Biosynthesized Ag-NPs Using Aspergillus niger (MK503444.1) in Antimicrobial, Anti-Cancer and Anti-Angiogenic Activities A Pasha, DV Kumbhakar, SS Sana, D Ravinder, BV Lakshmi, SK Kalangi, ... Frontiers in Pharmacology 12, 812474, 2022 | 20 | 2022 |
| Pharmacotherapeutics and Molecular Mechanism of Phytochemicals in Alleviating Hormone‐Responsive Breast Cancer S Rampogu, C Park, D Ravinder, M Son, A Baek, A Zeb, R Bavi, R Kumar, ... Oxidative Medicine and Cellular Longevity 2019 (1), 5189490, 2019 | 19 | 2019 |
| Overexpression of Secreted Phosphoprotein 1 (SPP1) predicts poor survival in HPV positive cervical cancer P Deepti, A Pasha, DV Kumbhakar, R Doneti, SK Heena, S Bhanoth, ... Gene 824, 146381, 2022 | 13 | 2022 |
| Screening and identification of potential iNOS inhibitors to curtail cervical cancer progression: an in silico drug repurposing approach PK Poleboyina, S Rampogu, R Doneti, A Pasha, SM Poleboyina, ... Applied Biochemistry and Biotechnology, 1-17, 2022 | 12 | 2022 |
| Natural Compound Modulates the Cervical Cancer Microenvironment—A Pharmacophore Guided Molecular Modelling Approaches KL Shailima Rampogu, Doneti Ravinder, Smita C Pawar Journal of Clinical Medicine 7 (12), 551, 2018 | 12 | 2018 |
| Virtual screening, molecular docking, and dynamic simulations revealed TGF-β1 potential inhibitors to curtail cervical cancer progression PK Poleboyina, U Naik, A Pasha, D Ravinder, S Bhanothu, ... Applied Biochemistry and Biotechnology 196 (3), 1316-1349, 2024 | 8 | 2024 |
| Entrectinib a plausible inhibitor for osteopontin (SPP1) in cervical cancer—integrated bioinformatic approach PK Poleboyina, M Alagumuthu, A Pasha, D Ravinder, D Pasumarthi, ... Applied Biochemistry and Biotechnology 195 (12), 7766-7795, 2023 | 6 | 2023 |
| Inhibition of DDX3 and COX-2 by forskolin and evaluation of anti-proliferative, pro-apoptotic effects on cervical cancer cells: molecular modelling and in vitro approaches D Ravinder, S Rampogu, G Dharmapuri, A Pasha, KW Lee, SC Pawar Medical Oncology 39 (6), 61, 2022 | 6 | 2022 |
| Comparison of Various Milk Samples Using Spectroscopy Chromatography, and Microscopic Analysis D Ravinder, P Gowtham, K Khatri, SC Pawar, M Botlagunta Journal of Food Science and Nutrition Research 4 (1), 12-22, 2021 | 4 | 2021 |
| Short communication for targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches-part 2 S Rampogu, G Lee, R Doneti, KW Lee Computational Biology and Chemistry 87, 107242, 2020 | 4 | 2020 |
| The importance of molecular diagnostic techniques on evaluation of cancers A Chittipolu, A Pasha, D Ravinder Molecular Diagnostics of Cancer, 2023 | 1 | 2023 |
| Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:—an in silico and in vitro approach R Doneti, A Pasha, M Botlagunta, SK Heena, VVVP Mutyala, SC Pawar Medical Oncology 39 (11), 179, 2022 | 1 | 2022 |
| Andrographolide Mitigates Cisplatin Resistance by Inhibiting SPP1 Regulated NF‐kB/iNOS/COX‐2 and PI3K/AKT Pathway in Cisplatin Resistant Cervical Carcinoma Cells A Pasha, D Ravinder, SC Pawar Drug Development Research 86 (1), e70052, 2025 | | 2025 |
| A review on mechanistic aspects of litchi fruit induced acute encephalopathy B Panda, A Momin, G Devabattula, R Doneti, A Khandwaye, C Godugu Toxicon, 108052, 2024 | | 2024 |
| Differential Expression of DDX3 and microRNAs in Response to Hormone and Cisplatin Against Cervical Cancer M Botlagunta, K Khatri, DB Madhavi, R Doneti, A Pasha, SC Pawar Eurasian Journal of Medicine and Oncology 6 (4), 307, 2022 | | 2022 |
| Celecoxib inhibits doxorubicin-induced expression of MRP-1, MRP-3 and ABCA2 efflux pumps in drug resistant HepG2 hepatocellular carcinoma cells MW Arunasree M. Kalle, Ravinder Doneti, Gangappa Dharmapuri, Roy R. Karnati ... Anti-cancer agents in medicinal chemistry, 2016 | | 2016 |
| ADMET Studies (Toxicological) of Plastic by Products in Causing Breast Cancer NIM Shailima DV Rampogu, Ravinder Doneti MOJ Proteomics & Bioinformatics 2 (Issue 3), 2015 | | 2015 |
Aruna Sree M KalleUniversity of HyderabadΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα uohyd.ac.in